DK0795604T3 - Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse - Google Patents

Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse

Info

Publication number
DK0795604T3
DK0795604T3 DK97830040T DK97830040T DK0795604T3 DK 0795604 T3 DK0795604 T3 DK 0795604T3 DK 97830040 T DK97830040 T DK 97830040T DK 97830040 T DK97830040 T DK 97830040T DK 0795604 T3 DK0795604 T3 DK 0795604T3
Authority
DK
Denmark
Prior art keywords
bile acid
bacterial strains
acid metabolism
strains
altered
Prior art date
Application number
DK97830040T
Other languages
Danish (da)
English (en)
Inventor
Vesely Renata Maria Cavaliere
Simone Claudio De
Original Assignee
Vesely Marco Emilio
Vesely Leonardo
Vesely Alessandro
Vesely Sara
Vesely Marina Eva
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0795604(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vesely Marco Emilio, Vesely Leonardo, Vesely Alessandro, Vesely Sara, Vesely Marina Eva, Simone Claudio De filed Critical Vesely Marco Emilio
Application granted granted Critical
Publication of DK0795604T3 publication Critical patent/DK0795604T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK97830040T 1996-03-11 1997-02-05 Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse DK0795604T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000468A IT1283225B1 (it) 1996-03-11 1996-03-11 Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle

Publications (1)

Publication Number Publication Date
DK0795604T3 true DK0795604T3 (da) 2003-10-27

Family

ID=11373572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97830040T DK0795604T3 (da) 1996-03-11 1997-02-05 Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse

Country Status (13)

Country Link
US (6) US6225104B1 (fr)
EP (1) EP0795604B1 (fr)
JP (1) JP4057091B2 (fr)
KR (1) KR100472061B1 (fr)
CN (1) CN1110547C (fr)
AT (1) ATE246509T1 (fr)
CA (1) CA2198518C (fr)
DE (1) DE69723898T2 (fr)
DK (1) DK0795604T3 (fr)
ES (1) ES2200145T3 (fr)
IT (1) IT1283225B1 (fr)
MX (1) MX9701816A (fr)
PT (1) PT795604E (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US7374606B2 (en) * 2003-06-27 2008-05-20 Canon Kabushiki Kaisha Water-based ink and ink recording method
EP2327718B1 (fr) * 2003-11-21 2016-03-23 Pfenex, Inc. Systèmes d'expression ameliorés à sécrétion du système SEC
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
EP1736164A4 (fr) * 2004-03-31 2009-06-24 Calpis Co Ltd Agent visant à empêcher ou supprimer l'hépatopathie et aliment fonctionnel pour empêcher ou supprimer l'hépatopathie
KR101491867B1 (ko) * 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
EP2266619B1 (fr) * 2008-03-04 2015-05-13 Dikovskiy, Aleksander Vladimirovich Composition pharmaceutique à base d'hépatoprotecteur et de prébiotique, fabrication et utilisation de celle-ci
WO2013109635A1 (fr) 2012-01-16 2013-07-25 Elizabeth Mckenna Compositions et méthodes utilisées pour traiter des maladies et des troubles hépatiques
WO2014047588A1 (fr) 2012-09-21 2014-03-27 Elizabeth Mckenna Compositions à base d'oligonucléotides cpg naturels et leurs utilisations thérapeutiques
EP3172973B1 (fr) * 2015-11-27 2020-04-08 DAFLORN Ltd. Formule probiotique, procédé pour sa préparation et son utilisation
SG11201804255QA (en) * 2015-12-14 2018-06-28 Metabogen Ab Treatment of intrahepatic cholestasis and related liver diseases
CN115569141B (zh) * 2022-10-17 2023-10-20 中国农业科学院兰州兽医研究所 脱氧胆酸在制备抗口腔链球菌产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1221734B (it) * 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1255241B (it) * 1992-07-22 1995-10-20 Simos Contos Derivato di acido biliare e suo uso in terapia
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol

Also Published As

Publication number Publication date
DE69723898D1 (de) 2003-09-11
ITMI960468A0 (fr) 1996-03-11
IT1283225B1 (it) 1998-04-16
US20010012629A1 (en) 2001-08-09
EP0795604B1 (fr) 2003-08-06
CA2198518A1 (fr) 1997-09-11
EP0795604A3 (fr) 1998-04-15
MX9701816A (es) 1998-04-30
JP4057091B2 (ja) 2008-03-05
USRE41276E1 (en) 2010-04-27
US20030082791A1 (en) 2003-05-01
US20040259227A1 (en) 2004-12-23
CN1165857A (zh) 1997-11-26
CN1110547C (zh) 2003-06-04
ES2200145T3 (es) 2004-03-01
EP0795604A2 (fr) 1997-09-17
ITMI960468A1 (it) 1997-09-11
JPH1086A (ja) 1998-01-06
ATE246509T1 (de) 2003-08-15
PT795604E (pt) 2003-12-31
DE69723898T2 (de) 2004-01-29
US6225104B1 (en) 2001-05-01
US20110217759A1 (en) 2011-09-08
KR100472061B1 (ko) 2005-07-08
US7959911B2 (en) 2011-06-14
CA2198518C (fr) 2010-04-13
KR970065708A (ko) 1997-10-13

Similar Documents

Publication Publication Date Title
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
WO1992019104A3 (fr) Compositions a base d'acides gras utilisees pour eliminer les infections existant dans des plantes
CA2289717A1 (fr) Nouveau traitement de la constipation
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
ATE400281T1 (de) Vaginales lactobacillus-medikament
HU9204029D0 (en) Proteolytic enzym inhibitors
WO1997040072A3 (fr) Proteines adam et leur utilisation
BR9506607A (pt) Composiçao e método para controlar o crescimento de pelo menos um microrganismo
BR9609041A (pt) "terapia de substituição para cáries dentais".
ATE186446T1 (de) Synergistische antimikrobielle zusammensetzungen, die 2-(thiocyanomethylthio)benzothiazol und eine organische säure enthalten
AU2509495A (en) Pharmaceutical formulations of cefaclor
BR9506608A (pt) Composição e método para controlar o crescimento de pelo menos um microorganismo e método para impedir a deterioração de um produto material ou meio causada por bactérias fungos ou ambos
CA2252958A1 (fr) Sels fongicides
AR009470A1 (es) COMPOSICIoN FARMACÉUTICA QUE CONTIENE CEPAS BACTERIANAS Y UTILES EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS CON O CAUSADAS POR ALTERACIONES EN EL METABOLISMO DE LOS ÁCIDOS BILIARES, Y USO DE LAS MISMAS.
PL306158A1 (en) Phenyl-substituted 1,4-dihydropyridines, method of obtaining them and therapeutic agents containing such compounds
DK0657431T3 (da) 4-Phenyl-3-substituerede 1,4-dihydropyridinestere med cerebral virkning.
DE59914749D1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung
NO941791L (no) Biocidmateriale og anvendelse derav
BR9704686A (pt) Grupos de bactérias e composição farmacêutica contendo tais grupos, e uso da mesma para impedir e tratar doenças associadas com, ou causadas pelo metabolismo alterado de ácido de bìlis.
WO1992018090A3 (fr) Compositions antimicrobiennes orales
NO963145L (no) Synergistiske antimicrobielle blandinger inneholdende metylen-bis(tiocyanat) og en organisk syre
ZA901320B (en) Compositions for the treatment of microbial infections
CA2135712A1 (fr) L'activite synergique du glutaraldehyde en presence d'oxydants
ES2036429A1 (es) Procedimiento de fabricacion de un aditivo de lacto-bacilos para piensos.